Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 273

1.

Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation.

Wani Y, Notohara K, Saegusa M, Tsukayama C.

Hum Pathol. 2008 Jul;39(7):1072-9. doi: 10.1016/j.humpath.2007.07.019. Epub 2008 May 20.

PMID:
18495206
[PubMed - indexed for MEDLINE]
2.

Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.

Houghton O, Connolly LE, McCluggage WG.

Histopathology. 2008 Aug;53(2):156-65. doi: 10.1111/j.1365-2559.2008.03083.x.

PMID:
18752499
[PubMed - indexed for MEDLINE]
3.

Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.

Orlandi A, Ferlosio A, Ciucci A, Francesconi A, Lifschitz-Mercer B, Gabbiani G, Spagnoli LG, Czernobilsky B.

Mod Pathol. 2006 Jun;19(6):797-803.

PMID:
16575402
[PubMed - indexed for MEDLINE]
Free Article
4.

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.

Am J Surg Pathol. 2008 Feb;32(2):304-15. doi: 10.1097/PAS.0b013e3181483ff8.

PMID:
18223334
[PubMed - indexed for MEDLINE]
5.

Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules.

Wani Y.

Histopathology. 2009 Mar;54(4):495-7. doi: 10.1111/j.1365-2559.2009.03248.x. No abstract available.

PMID:
19309406
[PubMed - indexed for MEDLINE]
6.

Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.

Saegusa M, Hamano M, Kuwata T, Yoshida T, Hashimura M, Akino F, Watanabe J, Kuramoto H, Okayasu I.

Cancer Sci. 2003 Jan;94(1):103-11.

PMID:
12708483
[PubMed - indexed for MEDLINE]
7.

Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.

Norimatsu Y, Moriya T, Kobayashi TK, Sakurai T, Shimizu K, Tsukayama C, Ohno E.

Ann Diagn Pathol. 2007 Apr;11(2):103-8.

PMID:
17349568
[PubMed - indexed for MEDLINE]
9.
10.

Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder.

Wani Y, Notohara K, Fujisawa M.

Virchows Arch. 2008 Nov;453(5):521-7. doi: 10.1007/s00428-008-0680-z. Epub 2008 Oct 9.

PMID:
18843504
[PubMed - indexed for MEDLINE]
11.

Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.

Shih HC, Shiozawa T, Miyamoto T, Kashima H, Feng YZ, Kurai M, Konishi I.

Anticancer Res. 2004 Nov-Dec;24(6):3843-50.

PMID:
15736420
[PubMed - indexed for MEDLINE]
Free Article
12.

A functional role of Cdx2 in beta-catenin signaling during transdifferentiation in endometrial carcinomas.

Saegusa M, Hashimura M, Kuwata T, Hamano M, Wani Y, Okayasu I.

Carcinogenesis. 2007 Sep;28(9):1885-92. Epub 2007 Apr 29.

PMID:
17468517
[PubMed - indexed for MEDLINE]
Free Article
13.

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.

Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, Richer JK.

Mod Pathol. 2008 Jul;21(7):912-23. doi: 10.1038/modpathol.2008.82. Epub 2008 May 16.

PMID:
18487993
[PubMed - indexed for MEDLINE]
Free Article
14.

Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.

Briese J, Schulte HM, Bamberger CM, Löning T, Bamberger AM.

Int J Gynecol Pathol. 2006 Apr;25(2):161-9.

PMID:
16633066
[PubMed - indexed for MEDLINE]
15.

Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.

Bircan S, Ensari A, Ozturk S, Erdogan N, Dundar I, Ortac F.

Pathol Oncol Res. 2005;11(1):32-9. Epub 2005 Mar 31.

PMID:
15800680
[PubMed - indexed for MEDLINE]
Free Article
16.

Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.

Brasanac D, Boricic I, Todorovic V, Tomanovic N, Radojevic S.

Br J Dermatol. 2005 Dec;153(6):1166-75.

PMID:
16307653
[PubMed - indexed for MEDLINE]
17.

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.

Saegusa M, Hashimura M, Yoshida T, Okayasu I.

Br J Cancer. 2001 Jan;84(2):209-17.

PMID:
11161379
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma.

Ohtani K, Sakamoto H, Rutherford T, Chen Z, Kikuchi A, Yamamoto T, Satoh K, Naftolin F.

Cancer Lett. 2002 May 8;179(1):79-86.

PMID:
11880185
[PubMed - indexed for MEDLINE]
19.
20.

Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.

Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N.

Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):226-32. doi: 10.1016/j.ejogrb.2008.01.004. Epub 2008 Mar 4.

PMID:
18295959
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk